Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.

Partial agonists exhibit a submaximal capacity to enhance the coupling of one receptor to an intracellular binding partner. Although a multitude of studies have reported different ligand-specific conformations for a given receptor, little is known about the mechanism by which different receptor conf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ralf C Kling, Nuska Tschammer, Harald Lanig, Timothy Clark, Peter Gmeiner
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9db6f013c0b64f99ae903a1fd26a6b9c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9db6f013c0b64f99ae903a1fd26a6b9c
record_format dspace
spelling oai:doaj.org-article:9db6f013c0b64f99ae903a1fd26a6b9c2021-11-18T08:15:34ZActive-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.1932-620310.1371/journal.pone.0100069https://doaj.org/article/9db6f013c0b64f99ae903a1fd26a6b9c2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24932547/?tool=EBIhttps://doaj.org/toc/1932-6203Partial agonists exhibit a submaximal capacity to enhance the coupling of one receptor to an intracellular binding partner. Although a multitude of studies have reported different ligand-specific conformations for a given receptor, little is known about the mechanism by which different receptor conformations are connected to the capacity to activate the coupling to G-proteins. We have now performed molecular-dynamics simulations employing our recently described active-state homology model of the dopamine D2 receptor-Gαi protein-complex coupled to the partial agonists aripiprazole and FAUC350, in order to understand the structural determinants of partial agonism better. We have compared our findings with our model of the D2R-Gαi-complex in the presence of the full agonist dopamine. The two partial agonists are capable of inducing different conformations of important structural motifs, including the extracellular loop regions, the binding pocket and, in particular, intracellular G-protein-binding domains. As G-protein-coupling to certain intracellular epitopes of the receptor is considered the key step of allosterically triggered nucleotide-exchange, it is tempting to assume that impaired coupling between the receptor and the G-protein caused by distinct ligand-specific conformations is a major determinant of partial agonist efficacy.Ralf C KlingNuska TschammerHarald LanigTimothy ClarkPeter GmeinerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e100069 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ralf C Kling
Nuska Tschammer
Harald Lanig
Timothy Clark
Peter Gmeiner
Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.
description Partial agonists exhibit a submaximal capacity to enhance the coupling of one receptor to an intracellular binding partner. Although a multitude of studies have reported different ligand-specific conformations for a given receptor, little is known about the mechanism by which different receptor conformations are connected to the capacity to activate the coupling to G-proteins. We have now performed molecular-dynamics simulations employing our recently described active-state homology model of the dopamine D2 receptor-Gαi protein-complex coupled to the partial agonists aripiprazole and FAUC350, in order to understand the structural determinants of partial agonism better. We have compared our findings with our model of the D2R-Gαi-complex in the presence of the full agonist dopamine. The two partial agonists are capable of inducing different conformations of important structural motifs, including the extracellular loop regions, the binding pocket and, in particular, intracellular G-protein-binding domains. As G-protein-coupling to certain intracellular epitopes of the receptor is considered the key step of allosterically triggered nucleotide-exchange, it is tempting to assume that impaired coupling between the receptor and the G-protein caused by distinct ligand-specific conformations is a major determinant of partial agonist efficacy.
format article
author Ralf C Kling
Nuska Tschammer
Harald Lanig
Timothy Clark
Peter Gmeiner
author_facet Ralf C Kling
Nuska Tschammer
Harald Lanig
Timothy Clark
Peter Gmeiner
author_sort Ralf C Kling
title Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.
title_short Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.
title_full Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.
title_fullStr Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.
title_full_unstemmed Active-state model of a dopamine D2 receptor-Gαi complex stabilized by aripiprazole-type partial agonists.
title_sort active-state model of a dopamine d2 receptor-gαi complex stabilized by aripiprazole-type partial agonists.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/9db6f013c0b64f99ae903a1fd26a6b9c
work_keys_str_mv AT ralfckling activestatemodelofadopamined2receptorgaicomplexstabilizedbyaripiprazoletypepartialagonists
AT nuskatschammer activestatemodelofadopamined2receptorgaicomplexstabilizedbyaripiprazoletypepartialagonists
AT haraldlanig activestatemodelofadopamined2receptorgaicomplexstabilizedbyaripiprazoletypepartialagonists
AT timothyclark activestatemodelofadopamined2receptorgaicomplexstabilizedbyaripiprazoletypepartialagonists
AT petergmeiner activestatemodelofadopamined2receptorgaicomplexstabilizedbyaripiprazoletypepartialagonists
_version_ 1718422000359178240